Skip to content
★ Sign in to follow
Total declarations
87
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (57 ops.)
€482k

Latest filing published 17 Mar 2011 for Emergent BioSolutions Inc..

Insider track record

Disclosed buys
0
Disclosed sells
57
Signal history

No signal scores available.

Kyle Keese: trading record in brief

Kyle Keese discloses dealings in Emergent BioSolutions Inc. to SEC (Form 4). In total, 87 filings cover trades dated from 29 May 2007 to 15 March 2011.

On the market, this insider has only sold: 57 sales, €482k in total. The amount is not disclosed for 1 filing. Besides market trades, the filings include 3 share grants and 24 option exercises.

The latest filing, published on 17 March 2011, reports a share grant in Emergent BioSolutions Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Kyle Keese

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations87 total

25 of 87 declarations